HC Wainwright & Co. upgrades Crescent Biopharma to Buy, sets $36 price target
HC Wainwright & Co. upgraded Crescent Biopharma's stock to Buy and set a price target of $36.00.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.